Koru Medical Systems (KRMD): Director reported a transaction in 41K shares
Joseph M. Jr. Manko, Director at Koru Medical Systems, reported a transaction of 41K shares.
- 41K
- Shares
- Traded
- Nov 26, 2025
- Filed
- Nov 26, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 19, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
What came next
- Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 5, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Mar 12, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Linda Tharby, President and Chief Executive Officer of KORU Medical Systems, Inc. (the “Company”), has announced her retirement as Chief Executive Officer effective June 30, 2026 (the “Transition Date”).”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Koru Medical Systems
For Koru Medical Systems, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KRMD page.
How this filing works
Explore the data
Other disclosures at Koru Medical Systems
- SEC Form 4Sep 9, 2026
- SEC Form 4Jun 15, 2026
- SEC Form 4Jun 15, 2026
- SEC Form 4May 20, 2026
- SEC Form 4May 20, 2026
- SEC Form 4May 18, 2026
Everything OQRO holds on this company is on its KRMD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data